Near-death Experience in ICU Survivors

Critical Illness Clinical Trial

Official title:

Incidence of Near-death Experiences Among Patients Who Survived a Critical Illness

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04279171
• Other study ID #: EMISI
• Status: Completed
• Start date: June 1, 2019
• Est. completion date: June 30, 2021

Study information

• Verified date: March 2022
• Source: University of Liege
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This observational study aims to describe the incidence of near-death experience (NDE) in patients who survived a critical illness. In order to help determine the potential risk factors of NDE, dissociative status and spirituality are also investigated. Finally, in patients who experienced NDE, a magnetic resonance imaging is performed to search for any structural modifications.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 126
• Est. completion date: June 30, 2021
• Est. primary completion date: June 30, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• All consecutive patients who survived critical illness

Exclusion Criteria:

• Glasgow Coma Scale < 15/15

• Confusion (CAM ICU scale)

• Refusal

Related Conditions & MeSH terms

• Critical Illness
• Death
• Near-Death Experience

Intervention

Diagnostic Test:
• Greyson NDE scale
Questionnaire to detect occurence of NDE. A NDE is identified if score > or = 7/32
• DES dissociation scale
Screening for dissociative symptoms
• WHOQOL-SRPB
WHOQOL-SRPB is an instrument developed to evaluate how spirituality, religiosity and personal beliefs (SRPB) are related to quality of life in health and health care.
• cerebral magnetic resonance imaging
Types of images to be acquired: T1, T2, Diffusion Weighted Imaging-DWI, Fluid Attenuated Inversion Recovery and spectroscopy

Locations

Country	Name	City	State
Belgium	University Hospital of Liège	Liège

Sponsors (1)

Lead Sponsor	Collaborator
University of Liege

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	NDE	NDE occurence during ICU stay, retrospectively detected by the Greyson scale. Greyson scale is a 16 items and 32 points scale. Minimal score is 0, maximal score is 32. A NDE is suspected when score is equal or higher than 7.	Greyson questionnaire is administered during the week following ICU discharge
Secondary	Quality of life estimation	Quality of life assessment, using EQ-5D-3L	one year after first interview
Secondary	NDE	NDE occurence during ICU stay, retrospectively detected by the Greyson scale.	one year after first interview
Secondary	MCQ (Memory Characteristics Questionnaire)	analyze of the phenomenological characteristics of real and imagined memories	one month after first interview